Abstract
Commentary to:
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine
Pierpaolo Correale, Salvatora Tindara Miano, Cinzia Remondo, Cristina Migali, Maria Saveria Rotundo, Paolo Macrì, Pierosandro Tagliaferri, Michele Caraglia, Giuseppe Gotti, Guido Francini